Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu-M vs Vaxigrip in Healthy Volunteers
NCT05297994Phase 2Completed
- Sponsor
- Saint Petersburg Scientific Research Institute of Vaccines and Serums
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen in influenza (2 arms), sponsored by Saint Petersburg Scientific Research Institute of Vaccines and Serums. Primary endpoints: Severity of observed local reactions and their relationship with the vaccination, Severity of observed system reactions and their relationship with the vaccination and 6 more. Started Oct 2016; status: completed.
02
Drugs
Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05297994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05297994.